{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:18:40Z","timestamp":1771039120328,"version":"3.50.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T00:00:00Z","timestamp":1187654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2007,11,15]]},"DOI":"10.1007\/s00404-007-0433-2","type":"journal-article","created":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T14:17:37Z","timestamp":1187619457000},"page":"1-13","source":"Crossref","is-referenced-by-count":37,"title":["Psychotropic medication during pregnancy and lactation"],"prefix":"10.1007","volume":"277","author":[{"given":"Sharmila J.","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,21]]},"reference":[{"key":"433_CR1","first-page":"67","volume-title":"Psychological aspects of women\u2019s health care: the interface between psychiatry and obstetrics and gynaecology","author":"LJ Miller","year":"2001","unstructured":"Miller LJ (2001) Psychiatric disorders during pregnancy. In: Stotland NL, Steward DE (eds) Psychological aspects of women\u2019s health care: the interface between psychiatry and obstetrics and gynaecology, 2nd edn. American Psychiatric Press, Washington, pp 67\u201393","edition":"2nd edn"},{"issue":"Suppl 2","key":"433_CR2","first-page":"18","volume":"59","author":"LS Cohen","year":"1998","unstructured":"Cohen LS, Rosenbaum JF (1998) Psychotropic use during pregnancy: weighing the risks. J Clin Psychiatry 59(Suppl 2):18\u201328","journal-title":"J Clin Psychiatry"},{"key":"433_CR3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ncl.2004.07.003","volume":"22","author":"L Levey","year":"2004","unstructured":"Levey L, Ragan K, Hower-Hartley A, Newport DJ, Stowe ZN (2004) Psychiatric disorders in pregnancy. Neurol Clin 22:863\u2013893","journal-title":"Neurol Clin"},{"key":"433_CR4","first-page":"21","volume":"11","author":"CL Duffy","year":"1983","unstructured":"Duffy CL (1983) Postpartum depression: identifying women at risk. Genesis 11:21","journal-title":"Genesis"},{"key":"433_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1037\/0021-843X.93.2.158","volume":"93","author":"MW O\u2019Hara","year":"1984","unstructured":"O\u2019Hara MW, Neunabar DJ, Zekosi EM (1984) Prospective study of postpartum depression: prevalence, course and predictive factors. J Abnorm Psychol 93:158\u2013171","journal-title":"J Abnorm Psychol"},{"key":"433_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0447.1984.tb01190.x","volume":"70","author":"TJ McNeil","year":"1984","unstructured":"McNeil TJ, Kaji L, Malquist-Larson A (1984) Women with non-organic psychosis: pregnancy\u2019s effect on mental health during pregnancy. Acta Psychiatr Scand 70:127\u2013139","journal-title":"Acta Psychiatr Scand"},{"key":"433_CR7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/ajp.149.7.947","volume":"149","author":"FN Neziroglu","year":"1992","unstructured":"Neziroglu FN, Anemone MA, Yaryura-Tobias JA (1992) Onset of obsessive compulsive disorder in pregnancy. Am J Psychiatry 149:947\u2013950","journal-title":"Am J Psychiatry"},{"key":"433_CR8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4088\/JCP.v58n0709","volume":"58","author":"KE Williams","year":"1997","unstructured":"Williams KE, Koran L (1997) Obsessive compulsive disorder in pregnancy, the puerperium and the premenstrum. J Clin Psychiatry 58:330\u2013334","journal-title":"J Clin Psychiatry"},{"key":"433_CR9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1192\/bjp.150.5.662","volume":"150","author":"RE Kendell","year":"1987","unstructured":"Kendell RE, Chalmers JC, Platz C (1987) Epidemiology of puerperal psychosis. Br J Psychiatry 150:662\u2013673","journal-title":"Br J Psychiatry"},{"key":"433_CR10","first-page":"156","volume":"54","author":"DA Sichel","year":"1993","unstructured":"Sichel DA, Cohen LS, Dimmock JA, Rosenbaum JF (1993) Postpartum obsessive compulsive disorders: a case series. J Clin Psychiatry 54:156\u2013159","journal-title":"J Clin Psychiatry"},{"key":"433_CR11","volume-title":"Madness and loss of motherhood: sexuality, reproduction and long-term mental illness","author":"RJ Apfel","year":"1993","unstructured":"Apfel RJ, Handel MH (1993) Madness and loss of motherhood: sexuality, reproduction and long-term mental illness. American Psychiatric Press, Washington"},{"key":"433_CR12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF01572557","volume":"35","author":"DE Sobel","year":"1961","unstructured":"Sobel DE (1961) Infant mortality and malformations in children of schizophrenic women. Psychiatr Q 35:60\u201364","journal-title":"Psychiatr Q"},{"key":"433_CR13","first-page":"165","volume-title":"Why mothers die 1997\u20131999. Confidential inquiries into maternal deaths in the United Kingdom","author":"M Oates","year":"2001","unstructured":"Oates M (2001) Death from psychiatric causes. In: Lewis G, Drife J (eds) Why mothers die 1997\u20131999. Confidential inquiries into maternal deaths in the United Kingdom. Royal College of Obstetricians and Gynaecologists Press, London, pp 165\u2013187"},{"key":"433_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/schbul\/23.4.623","volume":"23","author":"LJ Miller","year":"1997","unstructured":"Miller LJ (1997) Sexuality, reproduction and family planning in women with schizophrenia. Schizophr Bull 23:623\u2013625","journal-title":"Schizophr Bull"},{"key":"433_CR15","first-page":"582","volume":"154","author":"RA Dickson","year":"1997","unstructured":"Dickson RA, Edwards A (1997) Clozapine and fertility. Am J Psychiatry 154:582\u2013583","journal-title":"Am J Psychiatry"},{"key":"433_CR16","first-page":"239","volume":"8","author":"B Kaplan","year":"1995","unstructured":"Kaplan B, Modai I, Stoler M, Kitai E, Valevski A, Weizman A (1995) Clozapine treatment and risk of unplanned pregnancy. J Am Board Fam Pract 8:239\u2013241","journal-title":"J Am Board Fam Pract"},{"key":"433_CR17","first-page":"115","volume-title":"Womens\u2019 health and psychiatry","author":"KH Pearson","year":"2002","unstructured":"Pearson KH, Nonacs R, Cohen LS (2002) Practical guidelines for the treatment of psychiatric disorders during pregnancy. In: Pearson KH, Sonawalla SB, Rosenbaum JF (eds) Womens\u2019 health and psychiatry. Lippincott, Williams and Wilkins, Philadelphia, pp 115\u2013123"},{"key":"433_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/oxfordjournals.epirev.a036172","volume":"17","author":"ST Orr","year":"1995","unstructured":"Orr ST, Miller CA (1995) Maternal depressive symptoms and risk of poor pregnancy outcomes: review of the literature and preliminary findings. Epidemiol Rev 17:165\u2013171","journal-title":"Epidemiol Rev"},{"key":"433_CR19","first-page":"99","volume":"77","author":"L Murray","year":"1997","unstructured":"Murray L (1997) The impact of postnatal depression on infant development. J Child Psychol Psychiatry 77:99\u2013101","journal-title":"J Child Psychol Psychiatry"},{"key":"433_CR20","volume-title":"British National Formulary","author":"DK Mehta","year":"2006","unstructured":"Mehta DK (2006) British National Formulary. BMA Publishing Group Ltd, London"},{"key":"433_CR21","first-page":"123","volume-title":"Medical embryology","author":"J Langman","year":"1985","unstructured":"Langman J (1985) Human development: normal and abnormal. In: Langman J (ed) Medical embryology. Williams and Wilkins, Baltimore, pp 123"},{"key":"433_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0091-3057(76)90014-9","volume":"4","author":"I Coyle","year":"1976","unstructured":"Coyle I, Wayner M, Singer G (1976) Behavioural teratogenesis: a critical evaluation. Pharmacol Biochem Behav 4:191\u2013200","journal-title":"Pharmacol Biochem Behav"},{"key":"433_CR23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0041-008X(80)90367-1","volume":"53","author":"RT Robertson","year":"1980","unstructured":"Robertson RT, Majka JA, Peter CP, Bokelman DL (1980) Effects of prenatal exposure to chlorpromazine on postnatal development and behaviour of rats. Toxicol Appl Pharmacol 53:541\u2013549","journal-title":"Toxicol Appl Pharmacol"},{"key":"433_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6123(08)60506-3","volume":"73","author":"CK Kellogg","year":"1988","unstructured":"Kellogg CK (1988) Benzodiazepines: influence on the developing brain. Prog Brain Res 73:207\u2013228","journal-title":"Prog Brain Res"},{"key":"433_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF00433413","volume":"79","author":"C Kellogg","year":"1983","unstructured":"Kellogg C, Ison J, Miller J (1983) Prenatal diazepam exposure: effects on auditory temporal resolution in rats. Psychopharmacology 79:332\u2013337","journal-title":"Psychopharmacology"},{"key":"433_CR26","first-page":"823","volume-title":"Textbook of psychopharmacology","author":"ZN Stowe","year":"1998","unstructured":"Stowe ZN, Nemeroff CB (1998) Psychopharmacology during pregnancy and lactation. In: Schatzberg AF, Nemeroff CB (eds) Textbook of psychopharmacology. American Psychiatric Press, Washington, pp 823\u2013837"},{"key":"433_CR27","first-page":"337","volume-title":"Pharmacotherapy of depression: applications for the outpatient practitioner","author":"J Elia","year":"1990","unstructured":"Elia J, Simpson JM (1990) Antidepressant medications during pregnancy and lactation; foetal teratogenic and toxic effects. In: Amsterdam JD (ed) Pharmacotherapy of depression: applications for the outpatient practitioner. Marcel Dekker, New York, pp 337\u2013379"},{"key":"433_CR28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1176\/ajp.153.5.725","volume":"153","author":"LL Altshuler","year":"1996","unstructured":"Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, Mintz J (1996) Pharmacological management of psychiatric illness and pregnancy: dilemmas and guidelines. Am J Psychiatry 153:592\u2013606","journal-title":"Am J Psychiatry"},{"key":"433_CR29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/bmj.1.5802.745","volume":"2","author":"DL Crombie","year":"1972","unstructured":"Crombie DL, Pincent RJ, Fleming D (1972) Imipramine and pregnancy. Br Med J 2:745","journal-title":"Br Med J"},{"key":"433_CR30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0890-6238(96)00057-3","volume":"10","author":"PR McElhatton","year":"1996","unstructured":"McElhatton PR, Garbis HM, Elefant E, Vial T, Bellemin B, Mastroiacovo P, Arnon J, Rodriguez-Pinilla E, Schaefer T, Merlob P, Dal Verme S (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of anti-depressants. A collaborative study of the European Network of Teratology Information Service. Reprod Toxicol 10:285\u2013294","journal-title":"Reprod Toxicol"},{"key":"433_CR31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","volume":"159","author":"I Nulman","year":"2002","unstructured":"Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G (2002) Child development following exposure to tricyclic anti-depressants or fluoxetine throughout foetal life: a prospective controlled study. Am J Psychiatry 159:1889\u20131895","journal-title":"Am J Psychiatry"},{"key":"433_CR32","first-page":"629","volume":"66","author":"RK Ward","year":"2002","unstructured":"Ward RK, Zamorski MA (2002) Benefits and risks of psychiatric medications during pregnancy. Am Fam Physician 66:629\u2013636","journal-title":"Am Fam Physician"},{"key":"433_CR33","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/bmj.284.6332.1837-a","volume":"284","author":"L Cowe","year":"1982","unstructured":"Cowe L, Lloyd D, Dawling S (1982) Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J 284:1837\u20131838","journal-title":"Br Med J"},{"key":"433_CR34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0193-953X(03)00046-7","volume":"26","author":"R Nonacs","year":"2003","unstructured":"Nonacs R, Cohen L (2003) Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am 26:547\u2013562","journal-title":"Psychiatr Clin North Am"},{"key":"433_CR35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002280050664","volume":"55","author":"A Ericson","year":"1999","unstructured":"Ericson A, Kallen B, Wilholm B (1999) Delivery outcome after the use of anti-depressants in early pregnancy. Eur J Clin Pharmacol 55:503\u2013508","journal-title":"Eur J Clin Pharmacol"},{"key":"433_CR36","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","volume":"159","author":"GE Simon","year":"2002","unstructured":"Simon GE, Cunningham ML, Davies RL (2002) Outcomes of prenatal antidepressant exposure. Am J Psychiatry 159:2055\u20132061","journal-title":"Am J Psychiatry"},{"key":"433_CR37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/080352501300067596","volume":"90","author":"H Nordeng","year":"2001","unstructured":"Nordeng H, Lindemann R, Perminov KV, Reikvam A (2001) Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediat 90:288\u2013291","journal-title":"Acta Paediat"},{"key":"433_CR38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-199512000-00005","volume":"15","author":"DJ Goldstein","year":"1995","unstructured":"Goldstein DJ (1995) Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 15:417\u2013420","journal-title":"J Clin Psychopharmacol"},{"key":"433_CR39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","volume":"160","author":"V Hendrick","year":"2003","unstructured":"Hendrick V, Stowe Z, Altshuler LL, Hwang S, Lee E, Haynes D (2003) Placental passage of antidepressant medications. Am J Psychiatry 160:993\u2013996","journal-title":"Am J Psychiatry"},{"key":"433_CR40","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0006-3223(00)00877-5","volume":"48","author":"L Cohen","year":"2000","unstructured":"Cohen L, Heller V, Bailey J, Grush L, Ablon JS, Bouffard SM (2000) Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry 48:996\u20131000","journal-title":"Biol Psychiatry"},{"key":"433_CR41","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","volume":"156","author":"A Costei","year":"2002","unstructured":"Costei A, Kozer E, Ho T, Ito S, Koren G (2002) Perinatal outcome following third trimester exposure to paroxetine. Arch Paediatr Adolesc Med 156:1129\u20131132","journal-title":"Arch Paediatr Adolesc Med"},{"key":"433_CR42","unstructured":"Wogelius P, Norgaard M, Munk EM (2005) Maternal use of selective serotonin reuptake inhibitors and risk of adverse pregnancy outcome. Pharmacoepidem Drug Safety 14:S72\u2013S73. (www.mhra.gsi.gov.uk)"},{"key":"433_CR43","unstructured":"GlaxoSmithKline Clinical Trial Register (2005) Epidemiology Study: Updated preliminary report on Bupropion in pregnancy and the occurrence of cardiovascular and major congenital malformations. ( http:\/\/www.ctr.gsk.cp.uk\/Summary\/paroxetine\/studylist.asp )"},{"key":"433_CR44","unstructured":"Kallen B, Otterblad A, Olausson P. Anti-depressants drugs during pregnancy and infant congenital heart defect. An English translation of this information is available on the MHRA website (www.mhra.gsi.gov.uk)"},{"key":"433_CR45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1677\/joe.0.0300205","volume":"30","author":"E Poulson","year":"1964","unstructured":"Poulson E, Robson J (1964) Effect of phenelzine and some related compounds in pregnancy. J Endocrinol 30:205\u2013215","journal-title":"J Endocrinol"},{"key":"433_CR46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/apt.10.1.59","volume":"10","author":"D Kohen","year":"2004","unstructured":"Kohen D (2004) Psychotropic medication in pregnancy. Adv Psychiatric Treatment 10:59\u201366","journal-title":"Adv Psychiatric Treatment"},{"key":"433_CR47","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","volume":"158","author":"A Einarsen","year":"2001","unstructured":"Einarsen A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, Mastroiacovo P, Addis A, Matsui D, Schuler L, Einarson TR, Koren G (2001) Pregnancy outcome following gestational exposure to venlafaxine: a multicentre prospective controlled study. Am J Psychiatry 158:1728\u20131730","journal-title":"Am J Psychiatry"},{"key":"433_CR48","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","volume":"192","author":"B Chun-Fai-Chan","year":"2005","unstructured":"Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A, Shakir S, Einarson A (2005) Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynaecol 192:932\u2013936","journal-title":"Am J Obstet Gynaecol"},{"key":"433_CR49","first-page":"224","volume":"9","author":"A Waes Van","year":"1969","unstructured":"Van Waes A, Van De Velde E (1969) Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Psychopharmacol 9:224\u2013237","journal-title":"J Clin Psychopharmacol"},{"key":"433_CR50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.1975.03240130044026","volume":"231","author":"AE Kopelman","year":"1975","unstructured":"Kopelman AE, McCullar FW, Heggeness L (1975) Limb malformations following maternal use of haloperidol. JAMA 231:62\u201364","journal-title":"JAMA"},{"key":"433_CR51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9378(77)90029-1","volume":"128","author":"D Slone","year":"1977","unstructured":"Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S (1977) Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight and intelligence quotient score. Am J Obstet Gynaecol 128:486\u2013488","journal-title":"Am J Obstet Gynaecol"},{"key":"433_CR52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4684-5439-0_12","volume-title":"Psychiatric consultation in childbirth settings","author":"KL Wisner","year":"1988","unstructured":"Wisner KL, Perel JM (1988) Psychopharmacological agents and electro-convulsive therapy during pregnancy and the puerperium. In: Cohen PL (ed) Psychiatric consultation in childbirth settings. Plenum, New York, pp 165\u2013206"},{"key":"433_CR53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00002018-199716060-00006","volume":"16","author":"M Trixler","year":"1997","unstructured":"Trixler M, Tenyi T (1997) Antipsychotic use in pregnancy. What are the best treatment options? Drug Saf 16:403\u2013410","journal-title":"Drug Saf"},{"key":"433_CR54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S003329170003467X","volume":"26","author":"A Sacker","year":"1996","unstructured":"Sacker A, Done DJ, Crow TJ (1996) Obstetric complications in children born to parents with schizophrenia: a meta analysis of case control studies. Psychol Med 26:279\u2013287","journal-title":"Psychol Med"},{"key":"433_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00065-6","volume":"33","author":"BE Bennedsen","year":"1998","unstructured":"Bennedsen BE (1998) Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophrenia Res 33:1\u201326","journal-title":"Schizophrenia Res"},{"key":"433_CR56","unstructured":"Desmond MM, Rudolph AJ, Hill RM (1969) Behavioural alterations and infants born to mothers on psychoactive medication during pregnancy. In: Farrell (ed) Congenital mental retardation. University of Texas Press, Austin, pp 235\u2013244"},{"key":"433_CR57","first-page":"817","volume":"36","author":"LA Hauser","year":"1985","unstructured":"Hauser LA (1985) Pregnancy and psychotropic drugs. Hospital Commun Psychiatry 36:817\u2013818","journal-title":"Hospital Commun Psychiatry"},{"key":"433_CR58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3476(80)80504-X","volume":"97","author":"CG Falterman","year":"1980","unstructured":"Falterman CG, Richardson C (1980) Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J Pediatr 97:308\u2013310","journal-title":"J Pediatr"},{"key":"433_CR59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","volume":"66","author":"K McKenna","year":"2005","unstructured":"McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 66:444\u2013449","journal-title":"J Clin Psychiatry"},{"key":"433_CR60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00004714-200008000-00002","volume":"20","author":"DJ Goldstein","year":"2000","unstructured":"Goldstein DJ, Corbin LA, Fung MC (2000) Olanzapine exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 20:399\u2013403","journal-title":"J Clin Psychopharmacol"},{"key":"433_CR61","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1345\/aph.1D485","volume":"38","author":"S Gentile","year":"2004","unstructured":"Gentile S (2004) Clinical utilisation of atypical antipsychotics in pregnancy and lactation. Ann Pharmacotherapy 38:1265\u20131271","journal-title":"Ann Pharmacotherapy"},{"issue":"Suppl 4","key":"433_CR62","first-page":"42","volume":"63","author":"C Ernst","year":"2002","unstructured":"Ernst C, Goldberg J (2002) The reproductive safety profile of mood stabilisers, atypical antipsychotics and broad spectrum psychotropics. J Clin Psychiatry 63(Suppl 4):42\u201355","journal-title":"J Clin Psychiatry"},{"key":"433_CR63","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","volume":"271","author":"LS Cohen","year":"1994","unstructured":"Cohen LS, Friedman J, Jefferson JW, Johnson EM, Weiner ML (1994) A re-evaluation of risk of in utero exposure to lithium. JAMA 271:146\u2013150","journal-title":"JAMA"},{"key":"433_CR64","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0140-6736(74)91918-7","volume":"2","author":"JJ Nora","year":"1974","unstructured":"Nora JJ, Nora AH, Toews WH (1974) Lithium, Ebstein\u2019s anomaly and other congenital heart defects. Lancet 2:594\u2013595","journal-title":"Lancet"},{"key":"433_CR65","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/070674370204700503","volume":"47","author":"AC Viguera","year":"2002","unstructured":"Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R (2002) Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 47:426\u2013436","journal-title":"Can J Psychiatry"},{"key":"433_CR66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0447.1983.tb06991.x","volume":"68","author":"B Kallen","year":"1983","unstructured":"Kallen B, Tandberg A (1983) Lithium and pregnancy: a cohort study on manic depressive women. Acta Psychiatrica 68:134\u2013139","journal-title":"Acta Psychiatrica"},{"key":"433_CR67","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0022-3476(79)80610-1","volume":"94","author":"E Mizrahi","year":"1979","unstructured":"Mizrahi E, Hobbs J, Goldsmith D (1979) Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Paediatr 94:493\u2013495","journal-title":"J Paediatr"},{"key":"433_CR68","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(75)92578-7","volume":"1","author":"K Karlsson","year":"1975","unstructured":"Karlsson K, Lindstedt G, Lundberg P (1975) Transplacental lithium poisoning: reversible inhibition of foetal thyroid. Lancet 1:1295","journal-title":"Lancet"},{"issue":"suppl 6","key":"433_CR69","first-page":"57","volume":"59","author":"A Llewellyn","year":"1998","unstructured":"Llewellyn A, Stowe Z, Strader J (1998) The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 59(suppl 6):57\u201364","journal-title":"J Clin Psychiatry"},{"key":"433_CR70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1067\/mob.2002.123610","volume":"187","author":"J Pinelli","year":"2002","unstructured":"Pinelli J, Symington A, Cunningham K, Paes BA (2002) Case report and review of the perinatal implications of maternal lithium use. Am J Obset Gynecol 187:245\u2013249","journal-title":"Am J Obset Gynecol"},{"key":"433_CR71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0447.1976.tb00112.x","volume":"54","author":"M Schou","year":"1976","unstructured":"Schou M (1976) What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 54:193\u2013197","journal-title":"Acta Psychiatr Scand"},{"key":"433_CR72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00002018-199818020-00006","volume":"18","author":"M Schou","year":"1998","unstructured":"Schou M (1998) Treating recurrent affective disorders during and after pregnancy. What can be taken safely? Drug Saf 18:143\u2013152","journal-title":"Drug Saf"},{"key":"433_CR73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/pb.24.6.229","volume":"24","author":"K Williams","year":"2000","unstructured":"Williams K, Oke S (2000) Lithium and pregnancy. Drug Inf Quartery Psychiatric Bull 24:229\u2013231","journal-title":"Drug Inf Quartery Psychiatric Bull"},{"key":"433_CR74","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","volume":"2","author":"E Robert","year":"1982","unstructured":"Robert E, Guibaud P (1982) Maternal valproic acid and congenital neural tube defects. Lancet 2:937","journal-title":"Lancet"},{"key":"433_CR75","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(82)90018-6","volume":"2","author":"T Bjerkedal","year":"1982","unstructured":"Bjerkedal T, Czeizel A, Goujard J, Kallen B, Mastroiacova P, Nevin N, Oakley G Jr, Robert E (1982) Valproic acid and spina bifida. Lancet 2:1096","journal-title":"Lancet"},{"key":"433_CR76","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(86)80949-0","volume":"108","author":"E Jager-Roman","year":"1986","unstructured":"Jager-Roman E, Deichl A, Jakob S, Hartmann AM, Koch S, Rating D, Steldinger R, Nau H, Helge H (1986) Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. J Pediatr 108:997\u20131004","journal-title":"J Pediatr"},{"key":"433_CR77","volume-title":"A reference guide to foetal and neonatal risk: drugs in pregnancy and lactation","author":"GG Briggs","year":"1994","unstructured":"Briggs GG, Freeman RK, Yaffe SJ (1994) A reference guide to foetal and neonatal risk: drugs in pregnancy and lactation. Williams and Wilkins, Baltimore"},{"key":"433_CR78","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1651-2227.1996.tb14137.x","volume":"85","author":"S Koch","year":"1996","unstructured":"Koch S, Jager-Roman E, Losche G, Nau H, Rating D, Helge H (1996) Anti-epileptic treatment in pregnancy: drug side-effects in neonates and neurological outcome. Acta Paediatrica 85:739\u2013746","journal-title":"Acta Paediatrica"},{"key":"433_CR79","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jmg.32.9.724","volume":"32","author":"J Clayton-Smith","year":"1995","unstructured":"Clayton-Smith J, Donnai D (1995) Foetal valproate syndrome. J Med Genetics 32:724\u2013727","journal-title":"J Med Genetics"},{"key":"433_CR80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1981.00510030034003","volume":"38","author":"G Paulson","year":"1981","unstructured":"Paulson G, Paulson R (1981) Teratogenic effects of anticonvulsants. Arch Neurol 38:140\u2013143","journal-title":"Arch Neurol"},{"key":"433_CR81","first-page":"1109","volume-title":"APA textbook of psychopharmacology","author":"DJ Newport","year":"2004","unstructured":"Newport DJ, Fisher A, Graybeal S (2004) Psychopharmacology during pregnancy and lactation. In: Schatzberg AF, Nemeroff CB (eds) APA textbook of psychopharmacology, 3rd edn. American Psychiatric Press, Washington, pp 1109\u20131146","edition":"3rd edn"},{"key":"433_CR82","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","volume":"19","author":"JH DiLiberti","year":"1984","unstructured":"DiLiberti JH, Farndon PA, Dennis NR, Curry CJ (1984) The fetal valproate syndrome. Am J Med Genet 19:473\u2013481","journal-title":"Am J Med Genet"},{"key":"433_CR83","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jmg.24.11.692","volume":"24","author":"R Winter","year":"1987","unstructured":"Winter R, Donnai D, Burn J, Tucker SM (1987) Fetal valproate syndrome: is there a recognisable phenotype? J Med Genet 24:692\u2013695","journal-title":"J Med Genet"},{"issue":"7641","key":"433_CR84","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0140-6736(70)90636-7","volume":"1","author":"K Mountain","year":"1971","unstructured":"Mountain K, Hirsh J, Gallus A (1971) Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet 1(7641):265\u2013268","journal-title":"Lancet"},{"key":"433_CR85","first-page":"223","volume":"23","author":"D Kennedy","year":"1998","unstructured":"Kennedy D, Koren G (1998) Valproic acid use in pregnancy: issues in treating women of reproductive age. J Psychiatry Neurosci 23:223\u2013228","journal-title":"J Psychiatry Neurosci"},{"key":"433_CR86","doi-asserted-by":"crossref","first-page":"F124","DOI":"10.1136\/fn.83.2.F124","volume":"83","author":"F Ebbesen","year":"2000","unstructured":"Ebbesen F, Joergensen A, Hoseth E, Kaad PH, Moeller M, Holsteen V, Rix M (2000) Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child Fetal Neonatal Ed 83:F124\u2013129","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"433_CR87","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-0404.1985.tb00901.x","volume":"72","author":"A Philbert","year":"1985","unstructured":"Philbert A, Pedersen B, Dam M (1985) Concentration of valproate during pregnancy in the newborn and in breast milk. Acta Neurol Scand 72:460\u2013463","journal-title":"Acta Neurol Scand"},{"key":"433_CR88","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1994.03510340057034","volume":"271","author":"D Scolnik","year":"1994","unstructured":"Scolnik D, Nulman I Rovet J, Gladstone D, Czuchta D, Gardner HA, Gladstone R, Ashby P, Weksberg R, Einarson T (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine therapy. JAMA 271:767\u2013770","journal-title":"JAMA"},{"key":"433_CR89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0890-6238(01)00199-X","volume":"16","author":"S Matalon","year":"2002","unstructured":"Matalon S, Schechtman S, Goldzweig G, Ornoy A (2002) The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16:9\u201317","journal-title":"Reprod Toxicol"},{"key":"433_CR90","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM198906223202505","volume":"320","author":"K Jones","year":"1989","unstructured":"Jones K, Lacro R, Johnson K, Adams J (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661\u20131666","journal-title":"N Engl J Med"},{"key":"433_CR91","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","volume":"161","author":"K Yonkers","year":"2004","unstructured":"Yonkers K, Wisner K, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L (2004) Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 161:608\u2013620","journal-title":"Am J Psychiatry"},{"key":"433_CR92","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","volume":"317","author":"L Dolovich","year":"1998","unstructured":"Dolovich L, Addis A, Vaillancourt J, Power JD, Koren G, Einarson TR (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: a meta-analysis of cohort and case control studies. BMJ 317:839\u2013843","journal-title":"BMJ"},{"key":"433_CR93","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(77)91463-5","volume":"2","author":"K Haram","year":"1977","unstructured":"Haram K (1977) Floppy infant syndrome and maternal diazepam. Lancet 2:612\u2013613","journal-title":"Lancet"},{"key":"433_CR94","first-page":"275","volume":"9","author":"L Miller","year":"1991","unstructured":"Miller L (1991) Clinical strategies for the use of psychotropic drugs during pregnancy. Psychiatr Med 9:275\u2013298","journal-title":"Psychiatr Med"},{"key":"433_CR95","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198111263052205","volume":"305","author":"PC Rubin","year":"1981","unstructured":"Rubin PC (1981) Current concepts: beta-blockers in pregnancy. New Engl J Med 305:1323\u20131326","journal-title":"New Engl J Med"},{"key":"433_CR96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1542\/peds.93.1.137","volume":"93","author":"American Academy of Pediatrics Committee on Drugs","year":"1994","unstructured":"American Academy of Pediatrics Committee on Drugs (1994) The transfer of drugs and other chemicals into human milk. Pediatrics 93:137\u2013150","journal-title":"Pediatrics"},{"key":"433_CR97","first-page":"103","volume-title":"Handbook of female psychopharmacology","author":"I Nulman","year":"2003","unstructured":"Nulman I, Ito S, Koren G (2003) Anti-depressant medication and breast-feeding. In: Steiner M, Koren G (eds) Handbook of female psychopharmacology. Martin Dunitz, London, pp 103\u2013115"},{"key":"433_CR98","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/0277-9536(82)90096-X","volume":"16","author":"DM Fergusson","year":"1982","unstructured":"Fergusson DM, Beautrais AL, Silva PA (1982) Breast-feeding and cognitive development in the first seven years of life. Soc Sci Med 16:1705\u20131708","journal-title":"Soc Sci Med"},{"key":"433_CR99","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0140-6736(92)91329-7","volume":"339","author":"A Lucas","year":"1992","unstructured":"Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C (1992) Breast milk and subsequent intelligence quotient in children born pre-term. Lancet 339:261\u2013264","journal-title":"Lancet"},{"key":"433_CR100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v61n0202","volume":"61","author":"LH Chaudron","year":"2000","unstructured":"Chaudron LH, Jefferson JW (2000) Mood stabilisers during breast-feeding: a review. J Clin Psychiatry 61:79\u201390","journal-title":"J Clin Psychiatry"},{"issue":"suppl2","key":"433_CR101","first-page":"41","volume":"59","author":"A Llewellyn","year":"1998","unstructured":"Llewellyn A, Stowe ZN (1998) Psychotropic medications in lactation. J Clin Psychiatry 59(suppl2):41\u201352","journal-title":"J Clin Psychiatry"},{"key":"433_CR102","first-page":"69","volume":"12","author":"JF Mortola","year":"1989","unstructured":"Mortola JF (1989) The use of psychotropic agents in pregnancy and lactation. Women\u2019s Disorders 12:69\u201387","journal-title":"Women\u2019s Disorders"},{"key":"433_CR103","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0327(90)90092-M","volume":"19","author":"A Buist","year":"1990","unstructured":"Buist A, Norman TR, Dennerstein L (1990) Breast-feeding and the use of psychotropic medication: a review. J Affect Disord 19:197\u2013206","journal-title":"J Affect Disord"},{"key":"433_CR104","first-page":"1","volume":"3","author":"RA Suri","year":"1998","unstructured":"Suri RA, Altshuler LL, Burt VK, Hendrick VC (1998) Managing psychiatric medications in the breast-feeding woman. Medscape Womens Health 3:1\u201310","journal-title":"Medscape Womens Health"},{"key":"433_CR105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2165\/00003088-199427040-00003","volume":"27","author":"G Pons","year":"1994","unstructured":"Pons G, Rey E, Matheson I (1994) Excretion of psychoactive drugs into breast milk: pharmacokinetic principles and recommendations. Clin Pharmacokinet 27:270\u2013289","journal-title":"Clin Pharmacokinet"},{"key":"433_CR106","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/apt.11.5.371","volume":"11","author":"D Kohen","year":"2005","unstructured":"Kohen D (2005) Psychotropic medication and breast feeding. Adv Psychiatric Treatment 11:371\u2013379","journal-title":"Adv Psychiatric Treatment"},{"key":"433_CR107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00003088-198814040-00003","volume":"14","author":"HC Atkinson","year":"1988","unstructured":"Atkinson HC, Begg EJ, Darlow BA (1988) Drugs in human milk: clinical pharmacokinetic considerations. Clin Pharmacokinet 14:217\u2013240","journal-title":"Clin Pharmacokinet"},{"key":"433_CR108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00007691-198001000-00004","volume":"2","author":"AJ Atkinson Jr","year":"1980","unstructured":"Atkinson AJ Jr, Stec GP, Lertora JJ, Ruo TI, Thenot JP (1980) Impact of active metabolites on monitoring plasma concentrations of therapeutic drugs. Ther Drug Monit 2:19\u201327","journal-title":"Ther Drug Monit"},{"key":"433_CR109","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-198005060-00001","volume":"5","author":"PL Morselli","year":"1980","unstructured":"Morselli PL, Franco-Morselli R, Bossi L (1980) Clinical pharmacokinetics in newborns and infants: age related differences and therapeutic implications. Clin Pharmacokinet 5:485\u2013527","journal-title":"Clin Pharmacokinet"},{"key":"433_CR110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003088-197601020-00001","volume":"1","author":"PL Morselli","year":"1976","unstructured":"Morselli PL (1976) Clinical pharmacokinetics in neonates. Clin Pharmacokinet 1:81\u201398","journal-title":"Clin Pharmacokinet"},{"key":"433_CR111","first-page":"295","volume":"153","author":"KL Wisner","year":"1996","unstructured":"Wisner KL, Perel JM (1996) Nortriptyline treatment of breast-feeding women. Am J Psychiatry 153:295","journal-title":"Am J Psychiatry"},{"key":"433_CR112","first-page":"67","volume-title":"Drugs and human lactation","author":"PN Bennett","year":"1996","unstructured":"Bennett PN (1996) Use of the monographs on drugs. In: Bennett PN (ed) Drugs and human lactation. Elsevier, Amsterdam, pp 67\u201374"},{"key":"433_CR113","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1176\/ajp.137.7.855","volume":"137","author":"TF Bader","year":"1980","unstructured":"Bader TF, Newman K (1980) Amitryptyline in human breast milk and nursing infants\u2019 serum. Am J Psychiatry 137:855\u2013856","journal-title":"Am J Psychiatry"},{"key":"433_CR114","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1176\/ajp.143.12.1597","volume":"143","author":"HC Stancer","year":"1986","unstructured":"Stancer HC, Reed KL (1986) Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant\u2019s serum. Am J Psychiatry 143:1597\u20131600","journal-title":"Am J Psychiatry"},{"key":"433_CR115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/15563659109025744","volume":"29","author":"MS Schimmell","year":"1991","unstructured":"Schimmell MS, Katz EZ, Shaag Y, Pastuszak A, Koren G (1991) Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 29:479\u2013484","journal-title":"J Toxicol Clin Toxicol"},{"key":"433_CR116","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/ajp.148.9.1234","volume":"148","author":"KL Wisner","year":"1991","unstructured":"Wisner KL, Perel JM (1991) Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 148:1234\u20131236","journal-title":"Am J Psychiatry"},{"key":"433_CR117","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(85)90712-3","volume":"2","author":"I Matheson","year":"1985","unstructured":"Matheson I, Panda H, Alertsen AR (1985) Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet 2:1124","journal-title":"Lancet"},{"key":"433_CR118","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1192\/bjp.172.2.175","volume":"172","author":"K Yoshida","year":"1998","unstructured":"Yoshida K, Smith B, Craggs M, Kumar RC (1998) Fluoxetine in breast milk and development outcome of breast-fed infants. Br J Psychiatry 172:175\u2013178","journal-title":"Br J Psychiatry"},{"key":"433_CR119","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/000992280104001207","volume":"40","author":"TW Hale","year":"2001","unstructured":"Hale TW, Shum S, Grossberg M (2001) Fluoxetine toxicity in a breast-fed infant. Clin Paediatrics 40:681\u2013684","journal-title":"Clin Paediatrics"},{"key":"433_CR120","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4088\/JCP.v61n1104","volume":"61","author":"S Misri","year":"2000","unstructured":"Misri S, Kim J, Riggs KW, Kostaras X (2000) Paroxetine levels in postpartum depressed women, breast milk and infant serum. J Clin Psychiatry 61:828\u2013832","journal-title":"J Clin Psychiatry"},{"key":"433_CR121","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1192\/pb.19.9.551","volume":"19","author":"D Duncan","year":"1995","unstructured":"Duncan D, Taylor D (1995) Which anti-depressants are safe to use in breast-feeding mothers? Psychiatric Bull 19:551\u2013552","journal-title":"Psychiatric Bull"},{"key":"433_CR122","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00431-003-1391-8","volume":"163","author":"P Merlob","year":"2004","unstructured":"Merlob P, Stahl B, Sulkes J (2004) Paroxetine during breast feeding: infant weight gain and maternal adherence to counsel. Eur J Paediatr 163:135\u2013139","journal-title":"Eur J Paediatr"},{"key":"433_CR123","first-page":"243","volume":"56","author":"LL Altshuler","year":"1995","unstructured":"Altshuler LL, Burt VK, McMullen M, Hendrick V (1995) Breast-feeding and sertraline: a 24\u00a0hour analysis. J Clin Psychiatry 56:243\u2013245","journal-title":"J Clin Psychiatry"},{"key":"433_CR124","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1176\/ajp.154.9.1255","volume":"154","author":"ZN Stowe","year":"1997","unstructured":"Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A, Nemeroff CB (1997) Sertraline and desmethyl sertraline in human breast milk and nursing infants. Am J Psychiatry 154:1255\u20131260","journal-title":"Am J Psychiatry"},{"key":"433_CR125","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1176\/appi.ajp.161.6.1066","volume":"161","author":"A Weissman","year":"2004","unstructured":"Weissman A, Levy B, Hartz A, Bentler S, Donohue M, Ellingrod VL, Wisner KL (2004) Pooled analysis of antidepressant levels in lactating mothers, breast milk and nursing infants. Am J Psychiatry 161:1066\u20131078","journal-title":"Am J Psychiatry"},{"key":"433_CR126","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00007691-199704000-00021","volume":"19","author":"PN Jensen","year":"1997","unstructured":"Jensen PN, Olesen OV, Bertelsen A, Linnet K (1997) Citalopram and desmethylcitalopram concentration in breastmilk and serum of mother and infant. Therapeutic Drug Monitoring 19:236\u2013239","journal-title":"Therapeutic Drug Monitoring"},{"key":"433_CR127","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2125.1997.t01-1-00576.x","volume":"44","author":"O Spigset","year":"1997","unstructured":"Spigset O, Carleborg L, Ohman R, Norstrom A (1997) Excretion of citalopram in breast milk. Br J Clin Pharmacol 44:295\u2013298","journal-title":"Br J Clin Pharmacol"},{"key":"433_CR128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0002-9378(03)00868-8","volume":"190","author":"A Lee","year":"2004","unstructured":"Lee A, Woo J, Ito S (2004) Frequency of infant adverse effects that are associated with citalopram use during breast-feeding. Am J Obstet Gynaecol 190:218\u2013221","journal-title":"Am J Obstet Gynaecol"},{"key":"433_CR129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-2125.1998.00710.x","volume":"45","author":"KF Ilett","year":"1998","unstructured":"Ilett KF, Hacket LP, Dusci LJ, Roberts MJ, Kristensen JH, Paech M, Groves A, Yapp P (1998) Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 45:459\u2013462","journal-title":"Br J Clin Pharmacol"},{"key":"433_CR130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S0033291797005965","volume":"28","author":"K Yoshida","year":"1997","unstructured":"Yoshida K, Smith B, Craggs M, Kumar R (1997) Neuroleptic drugs in breast milk: a study of pharmacokinetics and possible adverse effects in breast-fed infants. Psychol Med 28:81\u201391","journal-title":"Psychol Med"},{"key":"433_CR131","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/bmj.282.6278.1746","volume":"282","author":"LJ Whalley","year":"1981","unstructured":"Whalley LJ, Blain PG, Prime JK (1981) Haloperidol secreted in breast milk. BMJ 282:1746\u20131747","journal-title":"BMJ"},{"key":"433_CR132","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1176\/appi.ajp.160.8.1428","volume":"160","author":"SJ Gardiner","year":"2003","unstructured":"Gardiner SJ, Kristensen JH, Begg EJ, Hackett LP, Wilson DA, Ilett KF, Kohan R, Rampono J (2003) Transfer of olanzapine into breast milk, calculation of infant drug dose and effect on breast fed infants. Am J Psychiatry 160:1428\u20131431","journal-title":"Am J Psychiatry"},{"key":"433_CR133","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1345\/aph.1D326","volume":"38","author":"KF Illett","year":"2004","unstructured":"Illett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ, Begg EJ (2004) Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacotherapy 38:273\u2013276","journal-title":"Ann Pharmacotherapy"},{"key":"433_CR134","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1176\/appi.ajp.161.9.1715-a","volume":"161","author":"A Lee","year":"2004","unstructured":"Lee A, Giesbrecht E, Dunn E, Ito S (2004) Excretion of quetiapine in breast milk. Am J Psychiatry 161:1715\u20131716","journal-title":"Am J Psychiatry"},{"key":"433_CR135","first-page":"197","volume":"6","author":"V Dev","year":"1995","unstructured":"Dev V, Krupp P (1995) Adverse event profile and safety of clozapine. Rev Contemporary Pharmacotherapy 6:197\u2013208","journal-title":"Rev Contemporary Pharmacotherapy"},{"key":"433_CR136","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","volume":"108","author":"American Academy of Pediatrics Committee on Drugs","year":"2001","unstructured":"American Academy of Pediatrics Committee on Drugs (2001) The transfer of drugs and other chemicals into human milk. Pediatrics 108:776\u2013789","journal-title":"Pediatrics"},{"key":"433_CR137","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/026988119901300108","volume":"13","author":"K Yoshida","year":"1999","unstructured":"Yoshida K, Smith B, Kumar RC (1999) Psychotropic drugs in mothers\u2019 milk: a comprehensive review of assay methods, pharmacokinetics and safety of breast feeding. J Psychopharmacol 13:64\u201380","journal-title":"J Psychopharmacol"},{"key":"433_CR138","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1177\/106002809202601215","volume":"26","author":"P Merlob","year":"1992","unstructured":"Merlob P, Mor M, Litvin A (1992) Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacotherapy 26:1563\u20131565","journal-title":"Ann Pharmacotherapy"},{"key":"433_CR139","first-page":"768","volume":"219","author":"H Nau","year":"1981","unstructured":"Nau H, Rating D, Koch S, Hauser I, Helge H (1981) Valproic acid and its metabolite: placental transfer, neonatal pharmacokinetics, transfer via mother\u2019s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Therapeutics 219:768\u2013777","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"433_CR140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4088\/JCP.v61n0304","volume":"61","author":"C Piontek","year":"2000","unstructured":"Piontek C, Baab S, Peindl KS, Wisner KL (2000) Serum valproate levels in 6 breast-feeding mother-infant pairs. J Clin Psychiatry 61:170\u2013172","journal-title":"J Clin Psychiatry"},{"key":"433_CR141","first-page":"135","volume":"47","author":"K Sivertz","year":"2005","unstructured":"Sivertz K (2005) The use of psychotropic medication in pregnancy and lactation. BC Med J 47:135\u2013138","journal-title":"BC Med J"},{"key":"433_CR142","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.104.1.e11","volume":"104","author":"CS Birnbaum","year":"1999","unstructured":"Birnbaum CS, Cohen LS, Bailey JW, Grush LR, Robertson LM, Stowe ZN (1999) Serum concentration of antidepressants and benzodiazepines in nursing infants: a case series. Paediatrics 104:e11","journal-title":"Paediatrics"},{"key":"433_CR143","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2125.1990.tb03774.x","volume":"30","author":"I Matheson","year":"1990","unstructured":"Matheson I, Sande HA, Gaillot J (1990) The excretion of zopiclone into breast milk. Br J Clin Pharmacol 30:267\u2013271","journal-title":"Br J Clin Pharmacol"},{"key":"433_CR144","volume-title":"Psychotropic drug directory","author":"S Bazire","year":"2003","unstructured":"Bazire S (2003) Psychotropic drug directory. Fivepin Publishing, Salisbury"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0433-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-007-0433-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0433-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T21:10:59Z","timestamp":1684012259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-007-0433-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,21]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,11,15]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1007\/s00404-007-0433-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,21]]}}}